Please provide your email address to receive an email when new articles are posted on . The TRPM8 receptor agonist increases natural tear production as early as day 1. Alcon also launched a campaign ...
Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results